AW
MRNA icon

ACG Wealth’s Moderna MRNA Stock Holding History

ACG Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,089
Closed -$156K – 725
2022
Q2 		$156K Buy
+1,089
New +$156K 0.03% 271
2022
Q1 		– Sell
-3,089
Closed -$785K – 316
2021
Q4 		$785K Sell
3,089
-3,104
-50% -$908K 0.11% 177
2021
Q3 		$2.38M Buy
6,193
+268
+5% +$98.8K 0.31% 69
2021
Q2 		$1.39M Buy
5,925
+209
+4% +$37.4K 0.18% 115
2021
Q1 		$748K Buy
+5,716
New +$828K 0.1% 154

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACG Wealth's MRNA Position: Q3 2022 in Review

ACG Wealth sold out of Moderna (MRNA) in Q3 2022, closing a stake of 1,089 shares — an estimated $156K sold.

ACG Wealth first reported a position in MRNA in Q1 2021 and held it in 5 quarters. The position peaked at $2.38M in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • ACG Wealth reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 1,089 Moderna shares in Q3 2022, an estimated $156K.
  • ACG Wealth first reported a position in Moderna in Q1 2021 and held it in 5 quarters.
  • ACG Wealth's Moderna position peaked at $2.38M in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.